{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "459",
                "513"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 zw\u0119\u017cenia cie\u015bni aorty"
        },
        {
            "identifier": "T2",
            "position": [
                "527",
                "552"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji metod\u0105 Crafoorda"
        },
        {
            "identifier": "T3",
            "position": [
                "554",
                "565"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "02.05.2016r"
        },
        {
            "identifier": "T4",
            "position": [
                "677",
                "686"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Captopril"
        },
        {
            "identifier": "T5",
            "position": [
                "687",
                "698"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "2 x 2mg po."
        },
        {
            "identifier": "T6",
            "position": [
                "842",
                "859"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "w  stanie  dobrym"
        },
        {
            "identifier": "T7",
            "position": [
                "935",
                "944"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Captopril"
        },
        {
            "icd": "ICD10:Q25.1",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Zw\u00c4\u0099\u00c5\u00bcenie cie\u00c5\u009bni aorty"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N2",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "arg1": "T3",
            "arg2": "T2",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T4",
            "arg2": "T5",
            "identifier": "R2",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q20.3|Rozpoznanie II: ICD10:Z98.8|Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 zw\u0119\u017cenia cie\u015bni aorty. \\x0aStan po operacji metod\u0105 Crafoorda (02.05.2016r.).\n------------------------------------------------\nZalecenia\n------------------------------------------------\nCaptopril 2 x 2mg po.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec 2  letni  w  stanie  dobrym  zosta\u0142  przyj\u0119ty  do  Kliniki   celem   przeprowadzenia  bada\u0144 \nOtrzymuje Captopril\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:8.25[10\\\\^3/ul]\n    RBC:4.30[10\\\\^6/ul]\n    HGB:11.7[g/dl]\n    HCT:32.8[%]\n    MCV:76.3[fl]\n    MCH:27.2[pg]\n    MCHC:35.7[g/dl]\n    PLT:351.0[10\\\\^3/ul]\n    RDW-SD:38.5[fl]\n    RDW-CV:14.0[%]\n    PDW:9.7[fl]\n    MPV:9.3[fl]\n    P-LCR:18.9[%]\n    PCT:0.3[%]\n    NEUTR#:2.96[10\\\\^3/ul]\n    NEUTR%:35.9[%]\n    LYMPH#:4.45[10\\\\^3/ul]\n    LYMPH%:53.9[%]\n    MONO#:0.61[10\\\\^3/ul]\n    MONO%:7.40[%]\n    EO#:0.20[10\\\\^3/ul]\n    EO%:2.40[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.397\n    pCO2:41.7[mmHg]\n    BE:0.70[mmol/L]\n    HCO3:25.1[mmol/L]\n    pO2:38.3[mmHg]\n    O2Sat:68.1[%]\n    Na - ABL:139[mmol/L]\n    K - ABL:5.1[mmol/L]\n    Cl - ABL:106[mmol/L]\n    Ca zj ABL:1.18[mmol/L]\n    Ht - ABL:36.1[%]\n    Hb ABL:11.7[g/dl]\n    FO2Hb:67.3[%]\n    FCOHb:0.8[%]\n    FMetHb:0.4[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:82[mg/dl]\n    mleczany:15[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nFibrynogen (F): FIB:3.15[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:38.4[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:11.7[s]\nCzas trombinowy (TT): TT:15.9[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:94[%]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:8.00[mg/dl]\nASPAT: AST:40.00[IU/L]\nALAT: ALT:36.00[IU/L]\nNT- proBNP: NTpBNP:390.00[pg/ml]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:117.0[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:85[cm]\neGFR (1-13r\u017c M) stand.wg.Schwartza  wsp. 0.550: eGFR 1-13M:155.8[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ25.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\nG21\nG25\n------------------------------------------------"
}